Target intelligence / Profile preview

Atypical kinase COQ8A, mitochondrial (COQ8A)

Target
COQ8A
Molecular classification
Enzyme, Kinase, Mitochondrial protein, Chaperone-like protein
01

Overview

Atypical kinase COQ8A, mitochondrial, is an enzyme critical for the biosynthesis of coenzyme Q10 (ubiquinone), which plays an essential role in mitochondrial oxidative phosphorylation by facilitating electron transport and ATP production. The COQ8A protein exhibits kinase activity, likely acting as a lipid or small molecule kinase within the mitochondrial inner membrane—though precise substrate specificity remains under investigation. It shows chaperone-like activity necessary for assembly and function of the coenzyme Q synthome. Genetic mutations disrupting COQ8A function can result in primary coenzyme Q10 deficiency, manifesting primarily as neurodegenerative disorders (notably cerebellar ataxia), myopathy, and kidney disease due to impaired energy production and increased oxidative stress. Coenzyme Q10 supplementation can rescue mitochondrial function in COQ8A deficiency, highlighting its essential role in cellular metabolism and suggesting potential avenues for therapy.

Other names
aarF domain-containing protein kinase 3ADCK3ARCA2CABC1Chaperone activity of bc1 complex-likeChaperone, ABC1 activity of bc1 complex homologCoenzyme Q protein 8ACoenzyme Q8 homologCOQ10D4COQ8SCAR9Chaperone-ABC1-likeAtypical kinase ADCK3Chaperone-ABC1 (activity of bc1 complex)-likeEC 2.7.-.-Coenzyme Q8 homolog (yeast)AarF domain containing kinase 3
02

Mechanism of action

Restoration of mitochondrial electron transport via ubiquinone biosynthesis/complex formation, antioxidant protection (for CoQ10 supplementation)

03

Biological functions

Coenzyme Q (ubiquinone) biosynthesisMitochondrial oxidative phosphorylationElectron transport chain functionRegulation of mitochondrial functionAntioxidant defenseADP/ATP bindingChaperone-like function in bc1 complex assembly
04

Disease associations

Neurodegenerative disease (COQ8A-ataxia)Primary coenzyme Q10 deficiencyMitochondrial dysfunction
05

Safety considerations

Potential for broader mitochondrial dysfunction across multiple organ systems (brain, muscle, kidney) in deficiency states; so far, no specific therapeutic targeting/adverse drug safety concerns for direct COQ8A inhibition or activation are established in clinical literature
06

Interacting drugs

Coenzyme Q10 (ubiquinone) supplementation
07

Biomarkers

Primary coenzyme Q10 deficiencyCOQ8A mutations (genetic biomarker)mitochondrial dysfunction

Beyond the preview

Go deeper on Atypical kinase COQ8A, mitochondrial (COQ8A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atypical kinase COQ8A, mitochondrial (COQ8A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call